Pure NMNH - 125 mg, 60 capsules

The Future of NAD+ Optimization is Here

Upgrade your longevity regimen with the next-generation NAD+ booster designed for faster, longer-lasting, and more potent NAD+ support. Unlike NMN or NR, NMNH fuels NAD+ production through a distinct and innovative synthesis pathway, offering a breakthrough approach to cellular energy and healthy aging.*

Preclinical studies highlight NMNH’s promise:

• Delivers a dramatic surge in NAD+ levels*
• Supports NAD+ production across multiple tissues*
• Provides up to 20 hours of continuous NAD+ support*
• Achieves results at a lower dose than other NAD+ boosters*

Groundbreaking Phase 1 human clinical findings further validate NMNH’s impact:

• Increases NAD+ levels up to 300% (500mg dose)*
• Reduces biological age up to 5 years (500mg dose)*
• Boosts feelings of energy and decreases fatigue*
• Optimizes emotional well-being*
• Enhances physical performance*

NMNH represents a major leap forward in NAD+ science, offering a powerful new way to support healthy aging through NAD+. Whether used alone or alongside other NAD+ boosters, NMNH can help fully optimize your anti-aging strategy.*

How it Works

• NMNH works through a unique metabolic pathway, first converting into NADH and then into NAD+.*
• Unlike NMN and NR, which depend on enzymes like NR kinase and NAM phosphoribosyltransferase, NMNH leverages adenosine kinase (AK) to increase the cellular NAD+ pool, bypassing the typical enzymatic steps required by other NAD+ precursors like NMN and NR.*
• In addition to supporting NAD+ production, NMNH may also enhance key biochemical pathways such as the Krebs cycle, where cells generate ATP by metabolizing nutrients, and glycolysis, where ATP is produced from glucose. These processes are vital for cellular energy production, growth, and repair.*

Testing and CoA 

Triple lab tested (see Certificate of Analysis)

What Makes Ours Better?

• Science-First Innovation: We use UthPeak™ NMNH, a next-generation ingredient from the makers of Uthever® NMN. As the first clinically supported NMNH on the market, UthPeak™ delivers proven safety and efficacy. This patent-pending crystalline form sets a new benchmark in NAD+ supplementation.
  
• Doctor-Formulated: Developed by our in-house science team in collaboration with leading wellness experts to address the root causes of aging.*
  
• Triple Lab Tested: Rigorously tested three times by independent third-party labs to guarantee unmatched potency and purity.     
  
• Full Transparency: In an industry full of misleading claims, we publish our third-party lab results—so you always know exactly what’s in every bottle. 
  
• Manufactured in the USA: Since 1988, we’ve proudly produced our supplements in FDA-regulated, GMP-certified facilities, ensuring the highest quality and safety standards.
  
• 100-Day Risk-Free Guarantee: We stand behind our products. Not satisfied? Reach out to our Santa Barbara, CA office for a full refund within 100 days – no hassle, no questions.
  

References:

¹ Zapata-Pérez R, Tammaro A, Schomakers BV, et al. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB J. 2021;35(4):e21456. 
² Liu Y, Luo C, Li T, et al. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. J Proteome Res. 2021;20(5):2596-2606. 
³ Yang Y, Zhang N, Zhang G, Sauve AA. NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. Nat Metab. 2020;2(4):364-379. 
⁴ Giroud-Gerbetant J, Joffraud M, Giner MP, et al. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor. Mol Metab. 
⁵ EffePharm. Preclinical study of UthPeak™ NMNH. https://www.uthever.com 
⁶ EffePharm. Phase 1 clinical trial of UthPeak™ NMNH [prepublished data]. https://www.uthever.com.